Pulpotomy Indications and Clinical Selection Criteria
Pulpotomy represents partial removal of vital or inflamed pulp tissue in primary molars, removing the diseased coronal pulp while retaining vital radicular pulp tissue to maintain physiologic root resorption and tooth support until natural exfoliation. This procedure differs fundamentally from complete pulpectomy (complete pulp removal) and preserves more vital tissue and function than extraction. Pulpotomy is indicated for primary molars with traumatic pulp exposure (pulp exposed during cavity preparation or during restoration removal), caries-induced pulp exposure with vital tissue present, and primary molars with extensive caries involving the pulp chamber.
Critical to pulpotomy selection is determination that the exposed or inflamed pulp represents vital tissue, not necrotic pulp. Vital tissue responds to stimuli and bleeds when cut; necrotic tissue does not respond and does not bleed. If the exposed pulp is vital and can be preserved, pulpotomy provides excellent outcomes and preserves the tooth. If the pulp is necrotic or if periapical infection exists, complete pulpectomy or extraction is necessary, as pulpotomy cannot address irreversible pulp tissue changes.
Contraindications to pulpotomy include necrotic pulp tissue identified through absence of bleeding response, clinical or radiographic evidence of periapical abscess or purulent drainage, extensive root resorption involving more than one-third of root length, uncontrolled behavior in the child preventing adequate treatment completion, and systemic medical conditions contraindicating treatment completion. In these situations, complete pulpectomy or extraction becomes the appropriate treatment.
Pulpotomy Technique and Surgical Steps
The pulpotomy procedure begins with local anesthesia administration adequate to control pain during coronal pulp removal. Buffered lidocaine 2% with 1:100,000 epinephrine is standard; nitrous oxide-oxygen inhalation anesthesia may improve cooperation in anxious children. Rubber dam isolation is essential, preventing saliva contamination and providing visibility and protection.
Access cavity preparation follows standard endodontic principles, creating occlusal access that reveals the full extent of the pulp chamber. Complete visualization of the pulp chamber opening is essential to confirm the extent of pulp involvement and to identify all pulp tissue that requires removal. The access cavity must be sized to provide adequate visualization and access for instrumentation without excessive tooth removal.
Coronal pulp removal is accomplished by creating a transverse cut approximately 1.5-2 mm below the pulpal opening, removing all coronal pulp tissue with rotating diamond or carbide burs under copious water spray. The cutting should be smooth and complete, removing all pulp tissue in the coronal chamber while preserving the deepest possible portion of pulp tissue. The radicular pulp tissue below the cut should appear vital, with normal color and responsive to stimulation.
Hemostasis—stopping the bleeding from the radicular pulp stump—is essential before placement of hemostatic agent or restorative material. The cut pulp surface bleeds initially as the tissue is rich in blood vessels; gentle pressure with sterile gauze or cotton pellets placed over the pulpal area for 30-60 seconds typically achieves hemostasis. If continued oozing persists after 60-90 seconds of pressure, the presence of periapical infection or pathology should be considered, and pulpectomy rather than pulpotomy may be more appropriate.
Hemostatic Agents: Formocresol, Ferric Sulfate, and MTA
Four primary hemostatic agents are used in pulpotomy: formocresol, ferric sulfate, mineral trioxide aggregate (MTA), and biodentine (calcium silicate-based material). Each agent differs in mechanism of hemostasis, antimicrobial action, biocompatibility, and success rates.
Formocresol (typically 1/5 concentration in propylene glycol) was historically the most widely used hemostatic agent for pulpotomy, with documented success rates of 85-90% in many studies. The mechanism includes protein cross-linking creating a desiccated tissue zone that arrests bleeding and fixates residual pulp tissue. Formocresol provides antimicrobial properties and has a long track record of clinical use. However, concerns regarding formaldehyde release and potential mutagenic effects, as well as the fixed tissue response creating a mummified rather than physiologic response, have led to reduced use in many countries.
Ferric sulfate is a chemical hemostatic agent creating a ferric-protein complex and ferric oxide plug at the tissue surface, achieving hemostasis through mechanical blockade rather than tissue fixation. Ferric sulfate solutions (typically 15.5%) provide rapid hemostasis (within 15-30 seconds of application) and carry lower systemic toxicity compared to formocresol. Published success rates for ferric sulfate pulpotomy range from 80-90%, comparable to formocresol. The ferric oxide that forms is gradually resorbed as normal physiologic response occurs.
Mineral trioxide aggregate (MTA) is a biocompatible powder containing tricalcium silicate, dicalcium silicate, tricalcium aluminate, and other components. When mixed with water, MTA provides hemostasis through the hydrophilic nature of the set material and provides excellent biocompatibility with pulp tissue and periapical tissues. MTA is highly alkaline (pH >12), providing antimicrobial properties and promoting periapical healing and hard tissue formation. Clinical studies report success rates of 85-95% with MTA pulpotomy, with excellent long-term outcomes including absence of pulp necrosis and normal pulp healing responses. The cost of MTA is substantially higher than ferric sulfate or formocresol, but the superior biocompatibility and treatment outcomes justify the cost difference.
Biodentine is a calcium silicate-based material engineered as a biocompatible dentin substitute material with fast set time (12 minutes) and bioactive properties. Early clinical studies report success rates comparable to MTA (approximately 85-90%) with excellent biocompatibility. The faster set time compared to MTA and superior handling characteristics make biodentine increasingly popular for pulpotomy hemostasis.
Comparative studies demonstrate that MTA and ferric sulfate provide superior outcomes compared to formocresol, with particularly superior long-term outcomes in MTA-treated teeth showing physiologic healing and normal pulp tissue responses. For newly initiated pulpotomy programs, ferric sulfate or MTA represent superior choices to formocresol based on contemporary evidence and safety considerations.
Application Technique for Hemostatic Agents
Hemostatic agent application technique varies based on agent type. Formocresol is applied by dampening cotton pellets with formocresol solution and placing them on the pulpal area for 5 minutes with gentle pressure maintained throughout. Excess formocresol is rinsed away with water and the pulpal area is dried.
Ferric sulfate is applied directly to the pulpal area by placing a cotton pellet dampened in ferric sulfate solution on the bleeding pulp stump for 15-30 seconds, or by direct application of ferric sulfate solution to the pulpal area. The ferric oxide precipitate forms almost immediately, creating a brown discoloration that indicates hemostasis has occurred. The ferric oxide layer should not be mechanically removed but rather allowed to remain as a biocompatible barrier.
MTA is mixed according to manufacturer instructions (typically 3:1 powder to water ratio) to achieve a thick creamy consistency, then placed directly into the pulp chamber using a syringe or hand instrument. The material is gently condensed onto the pulpal area using a damp cotton pellet or instrument tip. Setting time is approximately 45-60 minutes for conventional MTA, though accelerated forms may set more rapidly.
Biodentine is similarly prepared, mixed to a thick consistency, and placed directly into the pulp chamber. The faster set time (approximately 12 minutes) accelerates treatment completion compared to MTA. Gentle condensation ensures adaptation and eliminates voids.
Clinical Success Rates and Outcomes Comparison
Published literature comparing pulpotomy hemostatic agents demonstrates variable success rates depending on follow-up duration, study design, and definition of success. In most comparative studies, MTA and ferric sulfate demonstrate success rates of 85-95% at 12-24 month follow-up, compared to formocresol success rates of 80-90%. Success is defined as absence of clinical symptoms, absence of radiographic progression of periapical pathology, absence of internal root resorption, and absence of periosteal new bone formation.
Long-term studies (36-48 month follow-up) demonstrate superior outcomes with MTA and ferric sulfate compared to formocresol in preventing internal root resorption and maintaining normal pulp tissue responses. Formocresol-treated teeth show greater likelihood of internal resorption developing with time, potentially related to the tissue fixation response creating altered tissue response to normal stimuli.
Biodentine studies show success rates comparable to MTA with excellent long-term outcomes and physiologic pulp responses. The faster set time compared to MTA makes biodentine increasingly preferred in clinical practice when available.
Success rates are substantially influenced by tooth restoration following pulpotomy. Teeth restored with stainless steel crown demonstrate significantly higher success rates (approximately 90-95%) compared to teeth with adhesive resin restoration only (approximately 75-85%). The superior marginal adaptation and complete coverage provided by stainless steel crowns prevents recontamination through microleakage and provides mechanical support for the treated tooth.
Stainless Steel Crown Restoration and Marginal Adaptation
Stainless steel crowns represent the ideal restoration following pulpotomy for primary molars, providing complete coverage of the treated tooth, excellent marginal adaptation, superior retention, and minimal bacterial microleakage compared to alternative restoration materials. The crown should be selected to provide complete coverage of the tooth including smooth cervical margins with excellent adaptation to avoid subgingival overhangs that may irritate gingival tissue.
Crown selection requires measurement of mesiodistal and buccolingual tooth dimensions to choose appropriately sized crown. Crowns are typically slightly oversized initially, then contoured to appropriate size during fitting. The mesial and distal contact points should provide appropriate contact tightness with adjacent teeth. The occlusal surface should achieve appropriate contact with opposing teeth and opposing arch, with the crown following the natural contour of the occlusal surface.
Cementation with zinc oxide-eugenol (ZOE) or resin-modified glass ionomer cement (RMGIC) provides retention and sealing. ZOE cement is biocompatible, resorbable, and traditional choice; RMGIC provides faster set and good biocompatibility. Crown margins should be subgingival or slightly supragingival, with careful contouring to prevent gingival irritation.
The stainless steel crown should be placed at the time of pulpotomy or within one week maximum, not delayed for extended periods. Teeth awaiting crown restoration should have temporary restoration placed to prevent contamination of the pulpotomy site.
Radiographic Monitoring Protocol and Follow-Up
Radiographic monitoring following pulpotomy requires immediate post-operative radiograph confirming hemostatic agent application and appropriate restoration placement. Baseline radiographs document any pre-existing periapical conditions or internal resorption.
Follow-up radiographs are obtained at regular intervals: 6 months post-operative, 12 months, and 24 months. The radiographic assessment evaluates for (1) absence of internal resorption, (2) absence of external root resorption beyond normal physiologic resorption, (3) absence of periapical radiolucency or progression of existing lesions, (4) absence of periosteal new bone formation or cortical expansion, and (5) normal root resorption progression as the primary tooth approaches exfoliation.
Internal resorption appears as enlarged pulp canal outline with progressive widening of the canal space on sequential radiographs. This complication develops in approximately 5-15% of pulpotomy cases, with higher incidence in formocresol-treated teeth compared to ferric sulfate or MTA-treated teeth. Teeth developing internal resorption may still retain functionality until exfoliation if the resorption does not progress rapidly, though extraction may be necessary if extensive resorption compromises tooth integrity.
External root resorption beyond normal physiologic resorption may indicate pulp necrosis or periapical inflammation. Accelerated resorption with extensive bone loss and periapical pathology indicates treatment failure requiring extraction.
Failure Recognition and Management
Clinical failures of pulpotomy include development of spontaneous pain, abscess formation with swelling or purulent drainage, mobility of the tooth, and radiographic evidence of internal resorption or periapical inflammation. These findings indicate that the pulpotomy treatment was unsuccessful in arresting pulp disease.
Possible causes of pulpotomy failure include incomplete removal of inflamed or necrotic pulp tissue, recontamination through restoration failure, persistent or secondary infection developing from inadequate treatment, and pre-existing periapical inflammation at the time of pulpotomy that contraindicates pulpotomy. Some failures represent necrosis of the remaining radicular pulp, progressing to periapical involvement.
Management of failed pulpotomy includes re-treatment options (complete pulpectomy or conventional root canal therapy) or extraction. Complete pulpectomy offers tooth preservation if diagnosed early before extensive pathology develops. If extensive periapical infection exists or if the child's cooperation and general health do not support continued endodontic treatment, extraction and space maintenance becomes the appropriate choice.
Prevention of Post-operative Complications
Prevention of post-operative complications requires attention to technique, antimicrobial control, and adequate restoration. Ensuring complete hemostasis before placement of hemostatic agent prevents continued bleeding that may prevent proper agent adaptation. Adequate removal of contaminated coronal pulp tissue before it becomes necrotic arrests infection progression. Complete isolation with rubber dam and aseptic technique minimizes secondary contamination.
Selection of appropriate hemostatic agent—favoring MTA, ferric sulfate, or biodentine over formocresol—promotes physiologic healing and reduces internal resorption risk. Placement of stainless steel crown at the pulpotomy appointment prevents recontamination during the healing period. Regular radiographic monitoring enables early detection of complications for timely intervention.
---
References consolidated from citations above.